{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:25:39Z","timestamp":1787617539682,"version":"build-2736575974"},"reference-count":56,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Psoriasis is a common, chronic, and immune-mediated inflammatory skin disease recognized to lead to a wide range of comorbid disorders, mainly obesity. The study aimed to evaluate the problem of overweightness and obesity among psoriasis patients in the context of their prevalence and influence on the disease course. Materials and Methods: The study group encompassed 147 adult patients with plaque psoriasis. Results: The prevalences of overweightness (39.46%) and obesity (37.41%) demonstrated in the study showed the strong predisposition of psoriatic patients for abnormal body mass. The vast majority (77%) of subjects with psoriatic arthritis were overweight or obese. The results of the correlation analysis revealed the significant impacts of overweightness and obesity, as defined by the BMI index, on modifying the severity of psoriasis (as assessed by the PASI with a correlation coefficient of R = 0.23, p = 0.016; and BSA values with a correlation coefficient of R = 0.21, p = 0.023), particularly in contrast to patients with a normal body mass. Conclusions: Overweightness and obesity constitute a major health burden among psoriatic patients, influencing the disease course and severity. Enhanced understanding of the phenomenon may directly translate into improving disease management and overall patient care.<\/jats:p>","DOI":"10.3390\/medicina59112006","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T10:51:37Z","timestamp":1700045497000},"page":"2006","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["An Observational Study of 147 Psoriasis Patients: Overweightness and Obesity as a Significant Clinical Factors Correlated with Psoriasis"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-4892","authenticated-orcid":false,"given":"Anna","family":"Czarnecka","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1819-6593","authenticated-orcid":false,"given":"Monika","family":"Zab\u0142otna","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6089-8030","authenticated-orcid":false,"given":"Dorota","family":"Purzycka-Bohdan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4768-1387","authenticated-orcid":false,"given":"Roman J.","family":"Nowicki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Szczerkowska-Dobosz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"Global Psoriasis Atlas. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., and Ohtsuki, M. (2019). Risk Factors for the Development of Psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184347"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.det.2014.09.004","article-title":"Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities","volume":"33","author":"Ryan","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Barros, G., Duran, P., Vera, I., and Berm\u00fadez, V. (2022). Exploring the Links between Obesity and Psoriasis: A Comprehensive Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147499"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaad.2021.06.012","article-title":"Risk of psoriasis according to body mass index: A retrospective cohort analysis","volume":"86","author":"Norden","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/jir.2017.0105","article-title":"Bidirectional Association Between Psoriasis and Obesity: Benefits and Risks","volume":"38","author":"Ismail","year":"2018","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5114\/ada.2020.98284","article-title":"Pathogenesis of psoriasis in the \u201comic\u201d era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis","volume":"37","author":"Nedoszytko","year":"2020","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the UK","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40257-016-0211-7","article-title":"Considerations for Systemic Treatment of Psoriasis in Obese Patients","volume":"17","author":"Gisondi","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1468-3083.2011.04065.x","article-title":"Obesity and psoriasis: Body weight and body mass index influence the response to biological treatment","volume":"25","author":"Puig","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/13543784.2023.2219387","article-title":"The holistic approach to psoriasis patients with comorbidities: The role of investigational drugs","volume":"32","author":"Camela","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Duchnik, E., Kruk, J., Tuchowska, A., and Marchlewicz, M. (2023). The Impact of Diet and Physical Activity on Psoriasis: A Narrative Review of the Current Evidence. Nutrients, 15.","DOI":"10.3390\/nu15040840"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lee, H., Sim, N., Fotouhi, A., and Daveluy, S. (2023). Vegan Diet in Dermatology: A Review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185800"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/obr.12239","article-title":"Obesity and vitamin D deficiency: A systematic review and meta-analysis","volume":"16","author":"Costa","year":"2015","journal-title":"Obes. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1203426","DOI":"10.3389\/fmed.2023.1203426","article-title":"Serum vitamin D levels can be predictive of psoriasis flares up after COVID-19 vaccination: A retrospective case control study","volume":"10","author":"Karampinis","year":"2023","journal-title":"Front. Med."},{"key":"ref_18","unstructured":"Weir, C.B., and Jan, A. (2023). StatPearls [Internet], StatPearls Publishing. Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541070\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: A European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014A simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Purzycka-Bohdan, D., Kisielnicka, A., Zab\u0142otna, M., Nedoszytko, B., Nowicki, R.J., Reich, A., Samotij, D., Szcz\u0119ch, J., Krasowska, D., and Bartosi\u0144ska, J. (2022). Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051254"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bjd.16083","article-title":"HLA-Cw6 and psoriasis","volume":"178","author":"Chen","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_23","first-page":"505","article-title":"HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis","volume":"30","author":"Queiro","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sto\u015b, K., Rychlik, E., Wo\u017aniak, A., O\u0142tarzewski, M., Jankowski, M., Gujski, M., and Juszczyk, G. (2022). Prevalence and Sociodemographic Factors Associated with Overweight and Obesity among Adults in Poland: A 2019\/2020 Nationwide Cross-Sectional Survey. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19031502"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000433528","article-title":"Prevalence of Obesity in Patients with Psoriasis: Results of the National Study PsoHealth3","volume":"231","author":"Jacobi","year":"2015","journal-title":"Dermatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.12788\/cutis.0807","article-title":"Association Between Psoriasis and Obesity Among US Adults in the 2009\u20132014 National Health and Nutrition Examination Survey","volume":"112","author":"Smith","year":"2023","journal-title":"Cutis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000508303","article-title":"Obesity, but Not Metabolic Diseases, Is Associated with Risk of Psoriasis: A Population-Based Cohort Study in Taiwan","volume":"236","author":"Dai","year":"2020","journal-title":"Dermatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10654-018-0366-z","article-title":"Body mass index, abdominal fatness, weight gain and the risk of psoriasis: A systematic review and dose-response meta-analysis of prospective studies","volume":"33","author":"Aune","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.annepidem.2013.08.006","article-title":"The prevalence of obesity is increased in patients with late compared with early onset psoriasis","volume":"23","author":"Clemens","year":"2013","journal-title":"Ann. Epidemiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jid.2021.08.446","article-title":"Differences in Clinical Features and Comorbid Burden between HLA-C\u221706:02 Carrier Groups in >9,000 People with Psoriasis","volume":"142","author":"Douroudis","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"adv5209","DOI":"10.2340\/actadv.v103.5209","article-title":"Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of HLA-C*06:02 Status: The HUNT Study, Norway","volume":"103","author":"Solvin","year":"2023","journal-title":"Acta Derm. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Queiro, R., Coto-Segura, P., Bra\u00f1a, I., Pino, M., and Burger, S. (2022). Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C\u221706 Status. BioMed Res. Int., 2022.","DOI":"10.1155\/2022\/1451193"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1468-3083.2011.04289.x","article-title":"Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience","volume":"26","author":"Brazzelli","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00296-020-04734-x","article-title":"Trends in psoriatic arthritis epidemiology in Poland","volume":"41","author":"Wierzba","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s40744-021-00378-w","article-title":"Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis","volume":"8","author":"Zabotti","year":"2021","journal-title":"Rheumatol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10067-014-2630-2","article-title":"Tailored approach to early psoriatic arthritis patients: Clinical and ultrasonographic predictors for structural joint damage","volume":"34","author":"Youssef","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"ref_37","first-page":"721","article-title":"Obesity in early adulthood as a risk factor for psoriatic arthritis","volume":"146","author":"Wong","year":"2010","journal-title":"Arch. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjd.18227","article-title":"Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis","volume":"182","author":"Green","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"590749","DOI":"10.3389\/fimmu.2020.590749","article-title":"Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis","volume":"11","author":"Porta","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/PTT.S323300","article-title":"Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis","volume":"12","author":"Gisondi","year":"2022","journal-title":"Psoriasis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jid.2018.03.1522","article-title":"High-Fat Diet Exacerbates Early Psoriatic Skin Inflammation Independent of Obesity: Saturated Fatty Acids as Key Players","volume":"138","author":"Herbert","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/10408398.2020.1818053","article-title":"Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: An update for dermatologists and nutritionists","volume":"62","author":"Barrea","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e13751","DOI":"10.1111\/ijcp.13751","article-title":"Smoking habits amongst patients with psoriasis and the effect of smoking on clinical and treatment-associated characteristics: A cross-sectional study","volume":"75","author":"Hayran","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"883458","DOI":"10.3389\/fmed.2022.883458","article-title":"Prevalence of Tobacco Smoking and Its Association with Disease Severity Among Patients with Psoriasis in China: A Cross-Sectional Study","volume":"9","author":"Wei","year":"2022","journal-title":"Front. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1468-3083.2010.03860.x","article-title":"Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis","volume":"25","author":"Attwa","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jaad.2019.08.011","article-title":"Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination Survey","volume":"85","author":"Semenov","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.12670","article-title":"Psoriasis and smoking: A systematic review and meta-analysis","volume":"170","author":"Armstrong","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_48","first-page":"331","article-title":"The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years","volume":"32","author":"Nowicki","year":"2015","journal-title":"Adv. Dermatol. Allergol. Post\u0119py Dermatol. Alergol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/13556219871930","article-title":"Gender differences in the pharmacology of nicotine addiction","volume":"3","author":"Benowitz","year":"1998","journal-title":"Addict. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/ker349","article-title":"Differences in body mass index among individuals with PsA, psoriasis, RA and the general population","volume":"51","author":"Bhole","year":"2012","journal-title":"Rheumatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-4632.2011.05270.x","article-title":"Association between obesity measured by different parameters and severity of psoriasis","volume":"52","author":"Duarte","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2230.2012.04360.x","article-title":"Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis","volume":"37","author":"Ahdout","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2230.2008.02791.x","article-title":"Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity","volume":"34","author":"Murray","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review","volume":"27","author":"Horreau","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14740338.2023.2173170","article-title":"Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: Focus on pediatric patients","volume":"22","author":"Megna","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14740338.2023.2173171","article-title":"Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: Focus on elderly patients","volume":"22","author":"Megna","year":"2023","journal-title":"Expert Opin. Drug Saf."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/11\/2006\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:23:18Z","timestamp":1760131398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/11\/2006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["medicina59112006"],"URL":"https:\/\/doi.org\/10.3390\/medicina59112006","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]}}}